Literature DB >> 11149558

Anti-neutrophil cytoplasmic auto-antibodies (ANCA) in ulcerative colitis (UC): no relationship with disease activity.

D Reumaux1, J F Colombel, E Masy, B Duclos, D Heresbach, J Belaïche, A Cortot, P Duthilleul.   

Abstract

The relationship between anti-neutrophil cytoplasmic auto-antibodies (ANCA) and disease activity in inflammatory bowel diseases remains controversial. The aim of this study was to highlight the relationship between ANCA presence or titers and disease activity in ulcerative colitis (UC). Three groups of patients with UC were studied: 1) group A included 39 patients who had not undergone colectomy, 2) group B, 43 patients with subtotal colectomy and ileo-rectal anastomosis, 3) group C, 98 patients with proctocolectomy and ileo-anal anastomosis, including 88% with pouchitis and 12% without pouchitis at the time of the study. Determination of ANCA was performed using the standardized indirect immunofluorescence assay. ANCA were positive in 59%, 65%, and 54% of patients from groups A, B, and C, respectively (NS). No relationship between ANCA presence or titers and UC activity could be detected within groups A and B. In group C, 45 of 86 patients (52%) without pouchitis and 8 of 12 patients (67%) with pouchitis, were ANCA positive (NS). These results do not support a relationship between ANCA and UC activity in this cohort of 180 patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11149558     DOI: 10.1002/ibd.3780060403

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  6 in total

1.  Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease.

Authors:  E Israeli; I Grotto; B Gilburd; R D Balicer; E Goldin; A Wiik; Y Shoenfeld
Journal:  Gut       Date:  2005-09       Impact factor: 23.059

2.  Psychobiological subtypes of ulcerative colitis: pANCA status moderates the relationship between disease activity and psychological distress.

Authors:  Robert G Maunder; Gordon R Greenberg; Jonathan J Hunter; William J Lancee; A Hillary Steinhart; Mark S Silverberg
Journal:  Am J Gastroenterol       Date:  2006-10-04       Impact factor: 10.864

Review 3.  Pouchitis: insight into the pathogenesis and clinical aspects.

Authors:  Leandro Minatel Vidal de Negreiros; Lívia Bitencourt Pascoal; Lívia Moreira Genaro; Julian Furtado Silva; Bruno Lima Rodrigues; Michel Gardere Camargo; Carlos Augusto Real Martinez; Cláudio Saddy Rodrigues Coy; Maria de Lourdes Setsuko Ayrizono; João José Fagundes; Raquel Franco Leal
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

4.  Expression of Chemokine CCL28 in Ulcerative Colitis Patients.

Authors:  Dong Seok Lee; Kook Lae Lee; Ji Bong Jeong; Sue Shin; Su Hwan Kim; Ji Won Kim
Journal:  Gut Liver       Date:  2021-01-15       Impact factor: 4.519

5.  Role of Serum Proteinase 3 Antineutrophil Cytoplasmic Antibodies in the Diagnosis, Evaluation of Disease Severity, and Clinical Course of Ulcerative Colitis.

Authors:  So Imakiire; Hidetoshi Takedatsu; Keiichi Mitsuyama; Hideto Sakisaka; Kozo Tsuruta; Masaru Morita; Nobuaki Kuno; Koichi Abe; Sadahiro Funakoshi; Hideki Ishibashi; Shinichiro Yoshioka; Takuji Torimura; Fumihito Hirai
Journal:  Gut Liver       Date:  2022-01-15       Impact factor: 4.519

Review 6.  Serological markers of inflammatory bowel disease.

Authors:  Andrea Tesija Kuna
Journal:  Biochem Med (Zagreb)       Date:  2013       Impact factor: 2.313

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.